Sign Up Today and Learn More About Kardium Stock
Invest in or calculate the value of your shares in Kardium or other pre-IPO companies through EquityZen's platform.
Kardium Stock (KARU)
Kardium develops medical devices for the diagnosis and treatment of atrial fibrillation.
About Kardium Stock
Founded
2007
Industries
Software, Artificial Intelligence, Data and Analytics
Kardium is a technology pioneer working to advance medical device technology in the diagnosis and treatment of atrial fibrillation. Kardium was founded in 2007 and has built an outstanding team with a track record of excellence in medicine, business, and engineering. We have hired the best engineers, medical researchers and production staff and have been working with a team of top medical advisors to develop the Globe mapping and ablation system. The Globe system has been entirely developed by the team at Kardium and provides a complete system to assist in the diagnosis and treatment of atrial fibrillation. Kardium is based in Vancouver, Canada, and has consistently ranked as one of the top companies to work for in British Columbia.
Kardium Press Mentions
Stay in the know about the latest news on Kardium
Introducing Fierce Medtech's Fierce 15
fiercebiotech • Jun 02, 2025
PULSAR gives Kardium legs in PFA horse race
bioworld • May 06, 2025
Enhanced medical device for use in bodily cavities, for example an atrium
patents • May 04, 2025
High-density electrode-based medical device system
patents • May 04, 2025
Catheter navigation systems and methods
patents • May 04, 2025
Kardium Management
Leadership team at Kardium
Advisor
John Yeung
Advisor
John Webb
Join now and verify your accreditation status to gain access to:
- Kardium Current Valuation
- Kardium Stock Price
- Kardium Management
- Available deals in Kardium and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Kardium Cap Table and Funding History by Share Class and Liquidity Preferences
- Kardium Revenue and Financials
- Kardium Highlights
- Kardium Business Model
- Kardium Risk Factors
- Kardium Research Report from SACRA Research
Trading Kardium Stock
How to invest in Kardium stock?
Accredited investors can buy pre-IPO stock in companies like Kardium through EquityZen funds. These investments are made available by existing Kardium shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kardium stock?
Shareholders can sell their Kardium stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
